Cholera and Other Vibrioses in the United States

New England Journal of Medicine

Volumn 312, Issue 6, 1985, Pages 343-350

  Morris, J Glenn ^a   Black, Robert E ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA; EPIDEMIOLOGY; ETIOLOGY; HUMAN; PRIORITY JOURNAL; SHORT SURVEY; UNITED STATES; VIBRIO CHOLERAE; VIBRIO FLUVIALIS; VIBRIO VULNIFICUS; VIBRIOSIS;

EID: 0021916709     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM198502073120604     Document Type: Review

References (114)

1. van Heyningen WE, Seal JR. Cholera: the American scientific experience 1947–1980. Boulder, Colo.: Westview Press, 1983:8.
2. The cholera situation. Public Health Rep 1911; 26: 1104.
3. Cholera in the United States. Public Health Rep 1911; 26: 2083.
4. Weissman JB. DeWitt WE, Thompson J, et al. A case of cholera in Texas, 1973. Am J Epidemiol 1974; 100: 487–98.
5. Blake PA, Allegra DT, Snyder JD, et al. Cholera — a possible endemic focus in the United States. N Engl J Med 1980; 302: 305–9.
6. Shandcra WX, Hafkin B, Martin DL, et al. Persistence of cholera in the United States. Am J Trop Med Hyg 1983; 32: 812–7.
7. Johnston JM, Martin DL, Perdue J, et al. Cholera on a Gulf Coast oil rig. N Engl J Med 1983; 309: 523–6.
8. Lee JV, Shread P, Fumiss AL, Bryant TN. Taxonomy and description of Vibrio fluvialis sp. nov. (synonym group F vibrios, group EF6). J Appl Bactcriol 1981; 50: 73–94.
9. Davis BR, Fanning GR, Madden JM, et al. Characterization of biochemically atypical Vibrio cholerae strains, and designation of a new pathogenic species, Vibrio mimicus. J Clin Microbio! 1981; 14: 631–9.
10. Hickman FW, Farmer JJ III, Hollis DG, et al. Identification of Vibrio hollisae sp. nov. from patients with diarrhea. J Clin Microbio! 1982; 15: 395–401.
11. Farmer JJ III. Vibrio (Beneckae) vulnificus, the bacterium associated with sepsis, septicaemia, and the sea. Lancet 1979; 2: 903.
12. Love M, Teebken-Fisher D, Hose JE, Farmer JJ III, Hickman FW, Fanning GR. Vibrio damsela, a marine bacterium, causes skin ulcers on the damsclfish Chromis punctipinnis. Science 1981; 214: 1139–40.
13. Brenner DJ, Hickman-Brcnncr FW, Lee JV, et al. Vibrio furnissii (formerly aerogenic biogroup of Vibrio fluvialis), a new species isolated from human feces and the environment. J Clin Microbiol 1983; 18: 816–24.
14. Wachsmuth IK, Morris GK, Feeley JC Vibrio. In: Lennette EH, Balows A, Hausier WJ Jr, Truant JP, eds. Manual of clinical microbiology. 3rded. Washington, D.C: American Society for Microbiology, 1980.
15. Blake PA. Vibrios on the half shell: what the walrus and the carpenter didn't know. Ann Intern Med 1983; 99: 558–9.
16. Pierce NF, Mondai A. Clinical features of cholera. In: Barua D, Burrows W, eds. Cholera. Philadelphia: WB Saunders, 1974:209–20.
17. Blake PA, Mcrson MH, Weaver RE, Hollis DG, Heublein PC Disease caused by a marine vibrio: clinical characteristics and epidemiology. NEngl J Med 1979; 300: 1–5.
18. Smith HL Jr. Serotyping of non-cholera vibrios. J Clin Microbiol 1979; 10: 85–90.
19. Sakazaki R, Shimada T. Serovars of Vibrio cholerae. Jpn J Med Sci Biol 1977; 30: 279–82.
20. Nalin DR, Levine MM, Hornick RB, et al. The problem of emesis during oral glucose-electrolytes therapy given from the onset of severe cholera. Trans Soc Trop Med Hyg 1979; 73: 10–4.
21. Watten RH, Morgan FM, Songkhla YN, Vanikiati B, Phillips RA. Water and electrolyte studies in cholera. J Clin Invest 1959; 38: 1879–89.
22. Pierce NF, Sack RB, Mitra RC, et al. Replacement of water and electrolyte losses in cholera by an oral glucose-electrolyte solution. Ann Intern Med 1969; 70: 1173–81.
23. Hirschhorn N, Kinzie JL, Sachar DB, et al. Decrease in net stool output in cholera during intestinal perfusion with glucose-containing solutions. N Engl J Med 1968; 279: 176–81.
24. Bart KJ, Huq A, Khan M, Mosley WH. Seroepidemiologic studies during a simultaneous epidemic of infection with El Tor Ogawa and classical Inaba Vibrio cholerae. J Infect Dis 1970; 121: Suppl: S17–S24.
25. Schiraldi O, Benvcstilo V, Di Bari C, Moschetta R, Pastore G. Gastric abnormalities in cholera: epidcmiological and clinical considerations. Bull WHO 1974; 51: 349–52.
26. Black RE. The prophylaxis and therapy of secretory diarrhea. Med Clin North Am 1982; 66: 611–21.
27. Wallace CK, Anderson PN, Brown TC, et al. Optimal antibiotic therapy in cholera. Bull WHO 1968; 39: 239–45.
28. Karchmer AW, Curlin GT, Huq MI, Hirschhorn N. Furazolidone in paediatric cholera. Bull WHO 1970; 43: 373–8.
29. Finkclstcin RA. Cholera. CRC Crit Rev Microbiol 1973; 2: 553–623.
30. Holmgren J. Actions of cholera toxin and the prevention and treatment of cholera. Nature 1981; 292: 413–7.
31. Gill MD. Mechanisms of action of cholera toxin. Adv Cyclic Nuclcotidc Res 1977; 8: 85–118.
32. Gangarosa EI, Beisel WR, Bcnyajati C, Sprinz H, Piyaratn P. The nature of the gastrointestinal lesion in Asiatic cholera and its relation to pathogenesis: a biopsy study. Am J Trop Med Hyg 1960; 9: 125–35.
33. Levine MM, Kaper JB, Black RE, Clements ML. New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development. Microbiol Rev 1983; 47: 510–50.
34. Morris JG Jr, Picardi JL, Licb S, et al. Isolation of non-toxigenic Vibrio cholerae O group 1 from a patient with severe gastrointestinal disease. J Clin Microbiol 1984; 19: 296–7.
35. Levine MM, Kaper JB, Black RE, Clements ML, Morris JG. New insights into the pathogenesis of cholera and its prevention. Presented at the 19th Joint U.S.-Japan conference on Cholera, Bcthcsda, Maryland, October 17–19, 1983. abstract.
36. Kaper JB, Lockman HA, Baldini MM, Levine MM. Recombinant nontoxinogenic Vibrio cholerae strains as attenuated cholera vaccine candidates. Nature 1984; 308: 655–8.
37. Spira W, Sack D, Sanyal S, Madden J, McCardell B. Description of a possible new extracellular virulence factor in non-toxigenic V. cholerae Ol. Presented at the 19th Joint U.S.-Japan Conference on Cholera, Bcthesda, Maryland, October 17–19, 1983. abstract.
38. Sanyal SC, Alam K, Neogi PKB, Huq MI, Al-Mahmud KA. A new cholera toxin. Lancet 1983; 1: 1337.
39. Blake PA, Wachsmulh K, Davis BR, et al. Toxigenic vibrio cholerae Ol strain from Mexico identical to United States isolates. Lancet 1983; 2: 912.
40. Kaper JB, Bradford HB, Roberts NC, Falkow S. Molecular epidemiology of Vibrio cholerae in the U.S. Gulf Coast. J Clin Microbiol 1982; 16: 129–34.
41. Hughes JM, Hollis DG, Gangarosa EJ, Weaver RE. Non-cholera vibrio infections in the United States: clinical, cpidcmiologic, and laboratory features. Ann Intern Med 1978; 88: 602–6.
42. Morris JG Jr, Wilson R, Davis BR, et al. Non-O group I Vibrio cholerae gastroenteritis in the United States: clinical, cpidcmiologic, and laboratory aspects of sporadic cases. Ann Intern Med 1981; 94: 656–8.
43. Dakin WPH, Howcll DJ, Sutton RGA, O'Kecfe MF, Thomas P. Gastro enteritis due to non-agglutinable (non-cholera) vibrios. Med J Aust 1974; 2: 487–90.
44. Aldová E, Lázničková K, Štěpánková E, Lictava J. Isolation of nonagglutinablc vibrios from an enteritis outbreak in Czechoslovakia. J Infect Dis 1968; 118: 25–31.
45. Platia E, Vosti KL. Noncholcra vibrio septicemia. West J Med 1980; 132: 354–7.
46. Spira WM, Daniel RR, Ahmed QS, Huq A, Yusuf A, Sack DA. Clinical features and pathogenicity of O group I non-agglutinating Vibrio cholerae and other vibrios isolated from cases of diarrhea in Dacca, Bangladesh. In: Takcya J, Zinnaka Y, eds. Symposium on Cholera: Karatsu 1978: Proceedings of the 14 Joint Conference U.S.-Japan Cooperative Medical Science Program Cholera Panel. Ohta-ku, Tokyo: Toho University, 1978: 137–53.
47. Yamamoto K, Takcda Y, Miwatani T, Craig JP. Evidence that a non-Ol Vibrio cholerae produces enterotoxin that is similar but not identical to cholera enterotoxin. Infect Immun 1983; 41: 896–901.
48. Kaper JB, Moseley SL, Falkow S. Molecular characterization of environmental and non-toxigenic strains of Vibrio cholerae. Infect Immun 1981; 32: 661–7.
49. Spira WM, Fedorka-Cray PJ, Pcttcbone P. Colonization of the rabbit small inlestine by clinical and environmental isolates of non-Ol Vibrio cholerae and Vibrio mimicus. Infect Immun 1983; 41: 1175–83.
50. Nishibuchi M, Scidlcr RJ. Medium-dependent production of extracellular enterotoxins by non-O-1 Vibrio cholerae. Vibrio mimicus, and Vibrio fluvialis. Appl Environ Microbiol 1983; 45: 228–31.
51. Yamamoto K, Al-Omani M, Honda T, Takcda Y, Miwatani T. Non-Ol Vibrio cholerae hemolysin: purification, partial characterization, and immunological rclatcdness to El Tor hemolysin. Infect Immun 1984; 45: 192–6.
52. Kaper J, Lockman H, Colwell RR, Joseph SW. Ecology, scrology and enterotoxin production of Vibrio cholerae in Chesapeake Bay. Appl Environ Microbiol 1979; 37: 91–103.
53. Twcdt RM, Madden JM, Hunt JM, et al. Characterization of Vibrio cholerae isolated from oysters. Appl Environ Microbiol 1981; 41: 1475–8.
54. Davis JW, Sizemorc RK. Incidence of Vibrio species associated with blue crabs (Callinectes sapidus) collected from Galveston Bay, Texas. Appl Environ Microbiol 1982; 43: 1092–7.
55. Wilson R, Lieb S, Roberts A, et al. Non-0 group 1 Vibrio cholerae gastroenteritis associated with eating raw oysters. Am J Epidemiol 1981; 114: 293–8.
56. Acute gastroenteritis among tour groups to the Orient — United States. MMWR 1969; 18: 301–3.
57. Blake PA, Weaver RE, Hollis DG. Diseases of humans (other than cholera) caused by vibrios. Annu Rev Microbiol 1980; 34: 341–67.
58. Bonner JR, Cokcr AS, Berryman CR, Pollock HM. Spectrum of vibrio infections in a Gulf Coast community. Ann Intern Med 1983; 99: 464–9.
59. Barker WH Jr. Vibrio parahaemolyticus outbreaks in the United States. Lancet 1974; 1: 551–4.
60. Hughes JM, Boyce JM, Alccm ARMA, Wells JG, Rahman ASMM, Curlin GT. Vibrio parahaemolyticus enterocolitis in Bangladesh: report of an outbreak. Am J Trop Med Hyg 1978; 27: 106–12.
61. Bolen JL, Zamiska SA, Grecnough WB III. Clinical features-in enteritis due to Vibrio parahaemolyticus. Am J Med 1974; 57: 638–41.
62. Sakazaki R, Tamura K, Kato T, Obara Y, Yamai S, Hobo K. Studies on the enleropathogenic, facultatively halophilic bacteria, Vibrio parahaemolyticus. III. Enteropathogenicity. Jpn J Med Sci Biol 1968; 21: 325–31.
63. Miyamoto Y, Kato T, Obara Y, Akiyama S, Kinjiro T, Yamai S. In vitro hemolytic characteristic of Vibrio parahaemolyticus: its close correlation with human pathogenicity. J Bactcriol 1969; 100: 1147–9.
64. Joseph SW, Colwell RR, Kaper JB. Vibrio parahaemolyticus and related halophilic vibrios. CRC Crit Rev Microbiol 1983; 10: 77–124.
65. Kaper JB, Campen RK, Scidlcr RJ, Baldini MM, Falkow S. Cloning of the thermostable dirccl or Kanagawa phenomenon-associated hemolysin of Vibrio parahaemolyticus. Infect Immun 1984; 45: 290–2.
66. Takcda Y, Taga S, Miwatani T. Evidence that thermostable direct hemolysin of Vibrio parahaemolyticus is composed of two subunits. FEMS Microbiol Lett 1978; 4: 271–4.
67. Miyamoto Y, Obara Y, Nikkawa T, et al. Simplified purification and biophysicochemical characteristics of Kanagawa phenomenon-associated hemoiysin of Vibrio parahaemolyticus. Infect Immun 1980; 28: 567–76.
68. Twedt RM, Peeler JT, Spaulding PL. Effective ileal loop dose of Kanagawa-positive Vibrio parahaemolyticus. Appl Environ Microbiol 1980; 40: 1012–6.
69. Calia FM, Johnson DE. Bactcrcmia in suckling rabbits after oral challenge with Vibrio parahaemolyticus. Infect Immun 1975; 11: 1222–5.
70. Thompson CA Jr, Vanderzant C, Ray SM. Serological and hemolytic characteristics of Vibrio parahaemolyticus from marine sources. J Food Sci 1976; 41: 204–5.
71. Miwatani T, Takcda Y. Vibrio parahaemolyticus: a causative bacterium of food poisoning. Tokyo: Saikon, 1976.
72. Dadisman TA, Nelson R, Molenda JR, Garbcr HJ. Vibrio parahaemolyticus gastroenteritis in Maryland. 1. Clinical and cpidcmiologic aspects. Am J Epidemiol 1973; 96: 414–26.
73. Vibrio parahaemolyticus foodborne outbreak — Louisiana. MMWR 1978; 27: 345–6.
74. Huq MI, Alam AKMJ, Brenner DJ, Morris GK. Isolation of Wfcrw-like group, EF-6, from patients with diarrhea. J Clin Microbiol 1980; 11: 621–4.
75. Tacket CO, Hickman F, Pierce GV, Mendoza LF. Diarrhea associated with Vibrio fluvialis in the United States. J Clin Microbiol 1982; 16: 991–2.
76. Seidlcr RJ, Allen DA, Colwell RR, Joseph SW, Daily OP. Biochemical characteristics and virulence of environmental group F bacteria isolated in the United Stales. Appl Environ Microbiol 1980; 40: 715–20.
77. Lockwood DE, Kreger AS, Richardson SH. Detection of toxins produced by Vibrio fluvialis. Infect Immun 1982; 35: 702–8.
78. Shandera WX, Johnston JM, Davis BR, Blake PA. Disease from infection with Vibrio mimicus, a newly recognized Vibrio species. Ann Intern Med 1983; 99: 169–71.
79. Spira WM, Fedorka-Cray PJ. Production of cholera toxin-like toxin by Vibrio mimicus and non-Ol Vlbrio-cholerae: batch culture conditions for optimum yields and isolation of hypertoxigenic lincomycin-resislant mutants. Infect Immun 1983; 42: 501–9.
80. Morris JG Jr, Miller HG, Wilson R, et al. Illness caused by Vibrio damsela and Vibrio hollisac. Lancet 1982; 1: 1294–6.
81. An outbreak of acute gastroenteritis during a lour of the orient — Alaska. MMWR 1969; 18: 150.
82. Follow-up outbreak of gastroenteritis during a lour of the orient — Alaska. MMWR 1969; 18: 168.
83. Tacket CO, Brenner F, Blake PA. Clinical features and an cpidemiological study of Vibrio vulnificus infections. J Infect Dis 1984; 149: 558–61.
84. Johnston JM, McFarland LM, Becker SF. Vibrio vulnificus infections in Louisiana: a prospective investigation. Presented at the 23rd Intcrscicnce Conference on Antimicrobial Agents and Chemotherapy, Las Vegas, Nevada, October 24–26, 1983. abstract.
85. Kelly MT, McCormick WF. Acute bacterial myositis caused by Vibrio vulnificus. JAMA 1981; 246: 72–3.
86. Castillo LE, Winslow DL, Pankey GA. Wound infection and septic shock due to Vibrio vulnificus. Am J Trop Med Hyg 1981; 30: 844–8.
87. Pollak SJ, Parrish EF III, Barrett TJ, Drctler R, Morris JG Jr. Vibrio vulnificus septicemia: isolation of organism from stool and demonstration of antibodies by indirect immunofluorescence. Arch Intern Med 1983; 143: 837–8.
88. Poolc MD, Oliver JD. Experimental pathogenicity and mortality in ligated ileal loop studies of the newly reported halophilic lactose-positive Vibrio sp. Infect Immun 1978; 20: 126–9.
89. Bowdre JH, Poolc MD, Oliver JD. Edema and hemoconcentration in mice experimentally infected with Vibrio vulnificus. Infect Immun 1981; 32: 1193–9.
90. Wright Achéal, Simpson LM, Oliver JD. Role of iron in the pathogenesis of Vibrio vulnificus infections. Infect Immun 1981; 34: 503–7.
91. Kreger A, DeChatelct L, Shirley P. Interaction of Vibrio vulnificus with human polymorphonuclear leukocytes: association of virulence with resistencc to phagocytosis. J Infect Dis 1981; 144: 244–8.
92. Fierer J, Finley F. Deficient serum bactericidal activity against Escherichia coli in patients with cirrhosis of the liver. J Clin Invest 1979; 63: 912–21.
93. Carruthers MM, Kabat WJ. Vibrio vulnificus (lactose-positive vibrio) and Vibrio parahaemolyticus differ in their susceptibilities to human serum. Infect Immun 1981; 32: 964–6.
94. Idem. Isolation, purification, and characterization of a protease from Beneckea vulnifica (lactose-positive Vibrio, Vibrio vulnificus). Presented at the 81st Annual Meeting of the American Society for Microbiology, Dallas, March 1–6, 1981. abstract.
95. Smith GC, Merkel JR. Collagenolytic activity of Vibrio vulnificus: potential contribution to its invasiveness. Infect Immun 1982; 35: 1155–6.
96. Poole MD, Bowdre JH, Klapper D. Elastase produced by Vibrio vulnificus: in vitro and in vivo effects. Presented at the 82nd Annual Meeting of the American Society for Microbiology, Atlanta, March 7–12, 1982. abstract.
97. Kregcr A, Lockwood D. Detection of extracellular toxin(s) produced by Vibrio vulnificus. Infect Immun 1981; 33: 583–90.
98. Maneval DR, Wright Achéal, Marley GM, Patniak R, Morris JG. Characterization of an extracellular cytotoxin and other possible virulence factors of Vibrio vulnificus. Presented at the 24th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC, October 8–10, 1984. abstract.
99. Oliver JD, Warner RA, Cleland DR. Distribution of Vibrio vulnificus and other lactose-fermenting vibrios in the marine environment. Appl Environ Microbiol 1983; 45: 985–98.
100. Kelly MT. Effect of temperature and salinity on Vibrio (Beneckea) vulnificus occurrence in a Gulf Coast environment. Appl Environ Microbiol 1982; 44: 820–4.
101. Zen-Yoji H, LeClair RA, Ohta K, Montague TS. Comparison of Vibrio parahaemolyticus cultures isolated in the United States with those isolated in Japan. J Infect Dis 1973; 127: 237–41.
102. Schmidt U, Chmel H, Cobbs C. Vibrio alginolyticus infections in humans. J Clin Microbiol 1979; 10: 666–8.
103. Prociv P. Vibrio alginolyticus in Western Australia. Med J Aust 1978; 2: 296.
104. Hare P, Scott-Burden T, Woods DR. Characterization of extracellular alkaline proteases and collagenasc induction in Vibrio alginolyticus. J Gen Microbiol 1983; 129: 1141–7.
105. Reid GC, Woods DR, Rob FT. Peptone induction and rifampin-insensitive collagcnasc production by Vibrio alginolyticus. J Bacteriol 1980; 142: 447–54.
106. Kristensen KK. The occurrence of Vibrio parahaemolyticus and Vibrio alginolyticus in the Sound. Nord Vet Med 1974; 26: 188–196.
107. Golten C, Scheffers WA. Marine vibrios isolated from water along the Dutch coast. Neth J Sea Res 1975; 9: 351–64.
108. Krcgcr AS. Cytolytic activity and virulence of Vibrio damsela. Infect Immun 1984; 44: 326–31.
109. Lee JV, Donovan TJ, Furniss AL. Characterization, taxonomy, and emended description of Vibrio metschnikovii. Int J Sys Bacteriol 1978; 28: 99–111.
110. Jean-Jacques W, Rajashekaraiah KR, Farmer JJ III. Hickman FW, Morris JG, Kallick CA. Vibrio metschnikovii bacteremia in a patient with cholecystitis. J Clin Microbiol 1981; 14: 711–2.
111. Snyder JD, Allcgra DT, Levine MM, et al. serologic studies of naturally acquired infection with Vibrio cholerae serogroup Ol in the United States. J Infect Dis 1981; 143: 182–7.
112. Clements ML, Levine MM, Young CR, et al. Magnitude, kinetics, and duration of vibriocidal antibody responses in North Americans after ingestion of Vibrio cholerae. J Infect Dis 1982; 145: 465–73.
113. Bowdrc JH, Hull JH, Cocchctto DM. Antibiotic efficacy against Vibrio vulnificus in the mouse: superiority of tetracycline. J Pharmacol Exp Ther 1983; 225: 595–8.
114. Gangarosa EJ, Barker WH. Cholera: implications for the United States. JAMA 1974; 227: 170–1.